Adjuvant Olaparib in BRCA-Mutated Breast Cancer
N Engl J Med
.
2021 Oct 7;385(15):1439.
doi: 10.1056/NEJMc2112373.
Authors
Kazuki Nozawa
1
,
Akiyo Yoshimura
1
,
Hiroji Iwata
1
Affiliation
1
Aichi Cancer Center Hospital, Nagoya, Japan k.nozawa@aichi-cc.jp.
PMID:
34614336
DOI:
10.1056/NEJMc2112373
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Female
Humans
Phthalazines / therapeutic use
Piperazines / therapeutic use
Substances
Phthalazines
Piperazines
olaparib